Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension

Headache

Volumn 38, Issue 6, 1998, Pages 468-471

  Wheeler, Anthony H ^a,b  

^a Charlotte (NC) Spine Center

^b Charlotte Spine Center   (United States)

Author keywords

Botulinum toxin A; Migraine; Myofascial pain; Tension headache

Indexed keywords

ANALGESIC AGENT; BOTULINUM TOXIN A; NADOLOL; NONSTEROID ANTIINFLAMMATORY AGENT; SPASMOLYTIC AGENT; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BEHAVIOR THERAPY; CASE REPORT; COGNITIVE THERAPY; FEEDBACK SYSTEM; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MUSCLE TONE; MYALGIA; PHYSIOTHERAPY; PRIORITY JOURNAL; TENSION HEADACHE;

EID: 0031661081     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1998.3806468.x     Document Type: Article

References (19)

1. Rapoport AM. The diagnosis of migraine and tension-type headache, then and now. Neurology. 1992;42(suppl 2):11-15.
2. Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry. 1990;53:633-639.
3. Brin MF. Interventional neurology: treatment of neurological conditions with local injection of botulinum toxin. Arch Neurobiol. 1991;54(suppl 3):7-23.
4. Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18:17-21.
5. Blitzer A, Brin MF, Keen MS, Aviv JE. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg. 1993;119:1018-1022.
6. Carruthers A, Carruthers JD. The use of botulinum toxin to treat glabellar frown lines and other facial wrinkles. Cosmet Dermatol. 1994;7:5:11-15.
7. Guyuron B, Huddleston SW. Aesthetic indications for botulinum toxin injection. Plast Reconstr Surg. 1994; 93:913-918.
8. Keen M, Blitzer A, Aviv J, et al. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study. Plast Reconstr Surg. 1994; 94:94-99.
9. Carruthers A, Kiene K, Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol. 1996;34:788-797.
10. Acquadro MA, Borodic GE. Treatment of myofascial pain with botulinum A toxin. Anesthesiology. 1994;80:705-706.
11. Cheshire WP, Abashian SW, Mann JD. Botulinum toxin in the treatment of myofascial pain syndrome. Pain. 1994;59:65-69.
12. Tsui JK, Eisen A, Stoessl AJ, Calne S, Calne DB. Doubleblind study of botulinum toxin in spasmodic torticollis. Lancet. 1986;2:245-247.
13. Gelb DJ, Lowenstein DH, Aminoff MJ. Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology. 1989;39:80-84.
14. Blackie JD, Lees AJ. Botulinum toxin treatment in spasmodic torticollis. J Neurol Neurosurg Psychiatry. 1990;53:640-643.
15. Greene P, Kang U, Fahn S, Brin M, Moskowitz C, Flaster E. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology. 1990;40:1213-1218.
16. Poewe W, Schelosky L, Kleedorfer B, Heinen F, Wagner M, Deuschl G. Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients. J Neurol. 1992;239:21-25.
17. Simons DG. Clinical and etiological update of myofascial pain from trigger points. In: Clinical Overview and Pathogenesis of Fibromyalgia Syndrome, Myofascial Pain Syndrome, and Other Pain Syndromes. Binghamton, NY: Hayworth Medical Press; 1996:93-121.
18. Training guidelines for the use of botulinum toxin for the treatment of neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1994;44:2401-2403.
19. Jankovic J, Schwartz KS. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology. 1993;43:834-836.